Laryngotracheal Involvement as the Initial Manifestation of Relapsing Polychondritis  by Chang, Shu-Jen et al.
J Chin Med Assoc • June 2005 • Vol 68 • No 6 279
CASE  REPORT
Introduction
Relapsing polychondritis (RP) is an uncommon disease
with an unknown cause.1–6 However, antibodies against
type II collagen fibers may play a role in the pathogenesis
of the disease,3 which is characterized by recurrent
inflammation of cartilaginous tissues, including in
the ears, nose, peripheral joints, and laryngotracheo-
bronchial tree.1–6 In a report by McAdam et al,6 near-
ly 50% of patients had laryngotracheo-bronchial in-
volvement; however, only 12% of them had initial air-
way involvement.
RP is a systemic disease and can induce cardiovascular
disorders, such as aortitis, aneurysm, valvular heart
disease, and pericarditis.1–7 Patients with RP can also
have other hematologic, rheumatic, or autoimmune
diseases, including thyroid disorders.1,2,4–6 Here, we
present a case of RP that initially manifested with
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upper airway involvement. Typical auricular and nasal
chondritis, and scleritis, developed later. Ascending
aortic aneurysm and hyperthyroidism with thyroid
goiters were also found. We hope this case will
facilitate increased awareness about early airway
involvement in RP.
Case Report
A 58-year-old female patient had been well until April
2002, when she began to have an intermittent non-
productive cough and shortness of breath. At that
time, there were no fevers, chills, night sweating,
orthopnea, or lower-leg edema. Hoarseness and
choking ensued 6 months later. Dyspnea became
worse, and stridor developed intermittently thereafter.
The patient was treated for bronchial asthma, without
J Chin Med Assoc • June 2005 • Vol 68 • No 6280
S.J. Chang, et al
any significant improvement. She visited Chung-Hsin
Municipal Hospital in April 2003, where bronchoscopy
was performed. Subglottic stenosis was found, and the
patient experienced further dyspnea, so emergency
tracheostomy was performed that night.
Three months after tracheostomy, swelling,
tenderness and erythematous changes in both ears
were noted. Inflammation of the pinna persisted,
despite treatment with prednisolone 20 mg/day. Un-
der the impression of RP, the patient was admitted
to Taipei Veterans General Hospital for further
management. On admission, physical examination
disclosed “cauliflower” ears (Figure 1), saddle-nose,
periorbital lid edema, increased ocular discharge, and
scleritis. Fine rales over both lower lung fields were heard.
There was no heart murmur, arthritis or hearing loss.
Laboratory data revealed hemoglobin of 12.1 g/dL,
white blood cell count of 9,600/mL, and platelet
count of 4.5 = 105/mL. The serum level of C-reactive
protein was 1.34 mg/dL (normal, < 0.5 mg/dL), and
erythrocyte sedimentation rate was 134 mm/hour.
Renal and liver function tests, and immunoglobulin
(Ig) levels, including IgM, IgG and IgA, were all
within normal limits. Antinuclear autoantibody,
rheumatoid factor, and Venereal Disease Research
Laboratory test of serum were negative. Computed
tomography (CT) of the chest showed marked swelling
of cartilages of the trachea and bilateral main bronchus
(Figure 2), severe stenosis above the tracheostomy
(Figure 3), ascending aortic aneurysm, and bilateral
enlargement of the thyroid gland. Bronchoscopy found
that the lumen of the trachea above the tracheostomy
was nearly collapsed. The patient’s thyroid function
profile disclosed hyperthyroidism, with a thyroid
stimulating hormone level of 0.03 +IU/mL (normal,
0.25–4 +IU/mL), and free thyroxine level of 2.23
ng/dL (normal, 0.56–1.47 ng/dL).
The patient was treated with intravenous
methylprednisolone 30 mg every 6 hours, and
azathioprine 100 mg/day. The swelling of the ears
and scleritis of both eyes then improved slowly. The
dosage of prednisolone was tapered according to
clinical response. The patient has been taking
prednisolone 5 mg/day for more than 9 months
without any flare-up. However, complete laryngeal
collapse has persisted, and the deformed pinnae have
shown no improvement.
Discussion
RP is not a common disease, and the cause remains
unknown.1–6 The diagnostic criteria for RP proposed
Figure 3. Computed tomography of the chest showing severe
collapse of the upper airway lumen (arrow).
Figure 1. Pinna destruction with “cauliflower” deformity.
Figure 2. Computed tomography of the chest showing thickening
of the tracheal cartilage (arrows).
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Laryngotracheal involvement in relapsing polychondritis
by McAdam et al6 in 1976 comprise the following: 1)
recurrent chondritis of both auricles; 2) non-erosive
inflammatory polyarthritis; 3) chondritis of nasal
cartilages; 4) inflammation of ocular structures,
including conjunctivitis, keratitis, scleritis/episcleritis,
and/or uveitis; 5) chondritis of the respiratory tract
involving laryngeal and/or tracheal cartilages; 6)
cochlear and/or vestibular damage manifesting as
neurosensory hearing loss, tinnitus, and/or vertigo.
When 3 or more of these features are present, even
without biopsy confirmation, the diagnosis of RP is
definite.6 The initial presentations in our patient
included cough, shortness of breath, and nonspecific
respiratory symptoms, so RP was not considered
because the patient did not fulfill the abovementioned
criteria. Three months after tracheostomy, auricular
and nasal chondritis, and scleritis ensued, so a definite
diagnosis of RP was then established.
The pathogenesis of RP remains to be elucidated,
although autoantibodies against type II collagen
fibers may play a role.3 Indeed, patients with RP have
demonstrable serum levels of such autoantibodies,
and the autoantibody titer correlates with disease
activity.1,3 Biopsy of the involved cartilage is not
usually needed if the signs and symptoms are obvi-
ous.1,4 Histopathologic findings in affected carti-
lage specimens have revealed loss of normal cartilage
and inflammation of the perichondrium, which is
infiltrated by neutrophils, eosinophils, lymphocytes,
and plasma cells.1,4,6
The most commonly involved organs in RP include
the ears (85%), nose (62%), eyes (54%), and joints
(50–75%).1 The airways are affected in about 50–70%
of RP cases,2,5–7,10 but airway involvement as the initial
presentation is rare: such initial involvement was noted
in only 12% of cases in the report of McAdam et al.6
As in our case, airway manifestations of RP, such as
cough, hoarseness, dyspnea, stridor, wheezing, and
choking,2,4–6 can be misdiagnosed as bronchial asthma
or other airway diseases. Without adequate treatment,
respiratory tract involvement can be complicated by
airway collapse, which is the main cause of death in RP,
accounting for almost 30% of mortality.6,11
CT studies of the airway in RP can reveal cir-
cumferential thickening or a “worm-eaten” appear-
ance in affected cartilage; such changes suggest de-
formity or edema in the tracheal mucosa.8 In the late
stages, a narrowed, irregular and distorted airway
lumen will develop.9–11
The incidence of cardiovascular involvement in RP
is about 25–52%.1,2,4–7 Aortic aneurysm is a rare
complication in RP (about 2% of cases), and occurs
mostly in the ascending aorta.7 Other cardiovascular
findings may include valvular heart disease, conduc-
tion disturbances, arrhythmias, and pericarditis.1,2,4–7
About 30% of patients with RP have concurrent vas-
culitis, or autoimmune, hematologic, or connective-
tissue disease.1,2,4–6 In the study by McAdam et al,6
thyroid disease had a higher frequency associated
with RP (about 17%).
A standard treatment protocol for RP remains to
be established; however, corticosteroids are the agents
of choice for active inflammation. Methotrexate,
cyclosporine, azathioprine, and cyclophosphamide,
have all been used to treat RP, either because of their
steroid-sparing effects or for use in patients with life-
threatening disease.1,4,7 Recently, infliximab was
reported to have been used successfully to treat a refrac-
tory case of RP.12 If collapse of laryngeal or tracheal
cartilaginous rings or airway obstruction occur,
tracheostomy is indicated.9 If airway obstruction is
not severe, the placement of stents may be feasible.8
In summary, when a patient has recurrent cough,
dyspnea and stridor that do not respond to traditional
treatment for upper airway infection or bronchial
asthma, RP should be considered, even in the absence
of typical auricular, nasal, ocular or articular
manifestations. High doses of corticosteroids, or
emergency tracheostomy, should be performed im-
mediately if severe airway obstruction has developed.
We hope that this report will raise alertness about
potential early upper airway involvement in RP.
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